Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

8.7K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
8.7K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.9K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.9K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

8.2K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
8.2K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

5.8K
The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.8K
Abnormal Proliferation02:23

Abnormal Proliferation

5.3K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

7.4K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
7.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spatial CRISPR screens map total RNA in tissue.

Nature biotechnology·2026
Same author

Spatial Suitability of Peste des Petits Ruminants in North Africa Using Machine-Learning Ecological Niche Modeling.

Pathogens (Basel, Switzerland)·2026
Same author

Structural Basis for Potassium Inhibition of WNK Kinases.

Biochemistry·2026
Same author

Polarization-engineered aberration-resilient light sheet microscopy.

bioRxiv : the preprint server for biology·2026
Same author

How is agentic AI changing how we do science?

Cell systems·2026
Same author

Insulin and IGF signaling in the brain: multilevel regulation of synaptic and network homeostasis.

Frontiers in endocrinology·2026
Same journal

YhbO is a DJ-1 family glyoxalase and α-oxoaldehyde hydratase that confers resistance to reactive carbonyl stress (112).

The Journal of biological chemistry·2026
Same journal

ARMH3 acts as a central scaffold at the Golgi/TGN through interactions with Arl5, GBF1, and PI4KB.

The Journal of biological chemistry·2026
Same journal

PAX8 controls proximal tubule epithelial identity and stress response through epigenetic modification of distal regulatory elements.

The Journal of biological chemistry·2026
Same journal

Saturated cardiolipins are potent disruptors of inner mitochondrial membrane structure and function.

The Journal of biological chemistry·2026
Same journal

Phosphate release from myosin Va occurs after the initial powerstroke but before the secondary powerstroke associated with ADP-release.

The Journal of biological chemistry·2026
Same journal

Epigenetic silencing of miR-141 via core promoter methylation is associated with short-term bladder cancer progression.

The Journal of biological chemistry·2026
See all related articles

Related Experiment Video

Updated: Feb 21, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.5K

How activating mutations affect MEK1 regulation and function.

Granton A Jindal1,2,3, Yogesh Goyal1,2,3, John M Humphreys4

  • 1From the Departments of Chemical and Biological Engineering and.

The Journal of Biological Chemistry
|October 12, 2017
PubMed
Summary
This summary is machine-generated.

Mutations in the MEK1 gene can cause cancer by altering protein regulation. This study reveals how specific MEK1 variants become constitutively active, impacting cell signaling and development.

Keywords:
MEK1Raf kinasecancer biologymitogen-activated protein kinase (MAPK)protein phosphorylationzebrafish

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

835
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.4K

Related Experiment Videos

Last Updated: Feb 21, 2026

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods
07:49

Characterize Disease-related Mutants of RAF Family Kinases by Using a Set of Practical and Feasible Methods

Published on: July 17, 2019

6.5K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

835
Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation
15:05

Deciphering the Structural Effects of Activating EGFR Somatic Mutations with Molecular Dynamics Simulation

Published on: May 20, 2020

9.4K

Area of Science:

  • Molecular Biology
  • Cell Signaling
  • Genetics

Background:

  • The MEK1 kinase is a key component of the MAPK/ERK pathway, regulating cell growth and differentiation.
  • Disease-associated MEK1 mutations often lead to constitutive activity, but their regulatory mechanisms are poorly understood.
  • The Phe-53 residue in MEK1's negative regulatory region is implicated in disease pathogenesis.

Purpose of the Study:

  • To investigate the impact of Phe-53 MEK1 variants on kinase regulation and function.
  • To elucidate the mechanisms underlying MEK1 constitutive activity caused by pathogenic mutations.
  • To understand the developmental consequences of MEK1 activating mutations in vivo.

Main Methods:

  • Site-directed mutagenesis to create Phe-53 MEK1 variants.
  • In vitro kinase assays to measure MEK1 activity and phosphorylation by Raf.
  • Structural analysis to propose mechanisms of altered MEK1 conformation.
  • Zebrafish (Danio rerio) models to assess developmental effects.

Main Results:

  • Phe-53 MEK1 variants exhibit accelerated Raf-mediated phosphorylation compared to wild-type.
  • This enhanced phosphorylation further boosts the enzymatic activity of the variants.
  • Maximal activities of fully phosphorylated wild-type and mutant MEK1 are comparable.
  • Activating substitutions appear to destabilize MEK1's inactive conformation, promoting constitutive activity.
  • Zebrafish studies demonstrate that variant effects on development involve interplay between the negative regulatory region and activating phosphorylation.

Conclusions:

  • Pathogenic MEK1 mutations at Phe-53 enhance susceptibility to activating phosphorylation by Raf.
  • These mutations likely destabilize the inactive MEK1 conformation, leading to constitutive signaling.
  • The developmental impact of MEK1 variants results from combined effects of altered negative regulation and phosphorylation.
  • Understanding these complex regulatory mechanisms is crucial for targeting MEK1 in diseases like cancer.